[1] Xie Ss,Lin L,Ming L,et al. The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculosis pleurisy:a systematic review and meta analysis [J]. Oncotarget,2017, 8(47):83315-83322.
[2] Ying Luo, Ying Xue, Xueyun Guo, et al. Diagnostic value of pleural fluid T-SPOT for tuberculous pleurisy: An updated meta-analysis [J].Tuberculosis. 2020(122),101941.
[3] Wang et al. The pleural fluid lactate dehydrogenase/ adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions [J]. BMC Pulmonary Medicine 2017(17):168
[4] Aggarwal AN, Agarwa lR, Sehgal IS, Dhooria S. Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis [J]. PLOS ONE 14(3): e0213728.
[5] Yan-bin Wu, Zhijian Ye, Souming Qin et al. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy [J].Chinese Medical Journal. 126(17):3215–3221,
[6] Feng Zhu, Qinfang Ou, and Jian Zheng. Application Values of T-SPOT.TB in Clinical Rapid Diagnosis of Tuberculosis [J].Iran J Public Health. 2018 Jan; 47(1): 18–23.
[7] Ji et al. Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province, China [J].Infectious Diseases of Poverty .2017 (6):121
[8] Li D,Shen Y,Fu X,et al.Combined detections of interleukin-33 and adenosine deaminase for diagnosis of tuberculous pleural effusion[J].Int J Clin Exp Pathol,2015,8(1):888–893.
[9]Lee KS,Kim HR,Kwak S,et al.Association between Elevated Pleural Interleukin-33 Levels and Tuberculous Pleurisy[J] .Ann Lab Med,2013,33(1):45–51.
[10]Xuan WX,Zhang JC,Zhou Q,et al.IL-33 levels differentiate tuberculous pleurisy from malignant pleural effusions[J] .Oncol Lett,2014,8(1):449-453.
[11] Doosoo Jeon. Tuberculous Pleurisy: An Update [J]. Tuberc Respir Dis (Seoul). 2014,76(4): 153–159.
[12] Xiaoli Lei, Junli Wang, Zhigang Yang et al. Diagnostic Value of Pleural Effusion Mononuclear Cells Count and Adenosine Deaminase for Tuberculous Pleurisy Patients in China: A Case-Control Study [J]. Front Med (Lausanne). 2019; 6: 301.
[13] Schmitz J,Owyang A,Oldham E,et al.IL-33,an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J] .Immunity,2005,23(5):479-490.
[14] Blom L,Poulsen LK.IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures[J] .J Immunol,2012,189(9):4331-4337.
[15]Smithgall MD,Comeau MR,Yoon BR,et al.IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells[J] .Int Immunol,2008,20(8):1019–1030.
[16]Bourgeois E,Van LP,Samson M,et al.The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production[J] .Eur J Immunol,2009,39(4):1046–1055.
[17] Wood IS,Wang B,Trayhurn P.IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes[J].Biochem Biophys Res Commun,2009,384(1):105-109.
[18] Masamune A,Watanabe T,Kikuta K,et al.Nuclear expression of interleukin-33 in pancreatic stellate cells[J].Am J Physiol Gastrointest Liver Physiol,2010,299(4):G821-832.
[19] Xu D,Jiang HR,Kewin P,et al.IL-33 exacerbates antigen-induced arthritis by activating mast cells[J].Proc Natl Acad Sci U S A,2008,105(31):10913–10918.
[20] Préfontaine D,Lajoie-Kadoch S,Foley S et al.Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells[J].J Immunol,2009,183(8):5094–5103.
[21] Liang QL,Shi HZ,Wang K,Qin SM,Qin XJ. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis [J]. Respir Med 2008; 102: 744-54.
[22] LIUXQ, BIANSN, CHENGXH, etal. Utility of T-cell interferon-γ release assays for the diagnosis of female genital tuberculousis in a tertiary referral hospital in Beijing,China[J].Medicine (Baltimore),2016,95(44):e5200
[23] YANL,XIAOH,HANM,etal.Diagnostic value of T-SPOT.TB interferon-γ release assays for active tuberculosis[J].Exp Ther Med,2015,10(1):345-351
[24] PANL,JIAH,LIUF,etal.Risk factors for false-negative TSPOT.TB assay results in patients with pulmonary and extrapulmonaryTB[J].JInfect,2015,70(4):367-380.
[25] HAASMK,DALEYCL. Mycobacterial lung disease complicating HIV infection[J].Semin Respir Crit Care Med,2016,37 (2):230-242.